Anti-VEGF drugs making a difference in vision, longterm care

Two Duke University economists looked at Medicare beneficiaries with so-called "wet" macular degeneration and found those diagnosed after the introduction of anti-VEGF drugs were less likely to go blind and less likely to move into long-term care. "At last we have found a way of managing this horrible and very common disease among the oldest of the old," said Frank Sloan, who led the new study. Age-related macular degeneration (AMD) is the number one cause of blindness in the U.S. affecting older adults, usually after age 65. Most AMD patients have the dry form of the disease, but about 10 percent have wet AMD, which progresses more quickly than the dry form.



via Health News Headlines - Yahoo News http://ift.tt/1hYZ4DV